Kerr KE-29495 Revolution Formula2 Flowable Composite Syringe, A3 (Pack of 4)

Customer rating 4.7 stars

Imported from USA | Ships in 10 working days

5% additional discount on UPI | Cash On Delivery available

1

₹25580 -39% ₹15600/-

The price at cart2india.com is inclusive of custom duties, GST, freight forwarding and other charges.

Free Shipping across India. Powered by BlueDart.
EMI and GST Invoice available.

Product Information


Specification
Brand : Kerr
BulletPoint1 : Flowable light cure
BulletPoint2 : Four 1 g syringes with 20 tips
BulletPoint3 : Shade: A3
FdaDeviceClassification : ii
FdaIndicationOfUse : rx
FdaInstructionsForUseType : professional
FdaLabelType : rx_only
IsExpirationDatedProduct : 1
ItemName : Kerr KE-29495 Revolution Formula2 Flowable Composite Syringe, A3 (Pack of 4)
ItemPackageDimensions_Height : 1 inches
ItemPackageDimensions_Length : 1 inches
ItemPackageDimensions_Width : 1 inches
ItemPackageQuantity : 1
ItemTypeKeyword : professional-universal-dental-composites
Manufacturer : Kerr Corporation
ModelNumber : KE-29495
NumberOfBoxes : 1
NumberOfItems : 4
PartNumber : KE-29495
ProductExpirationType : Expiration Date Required
ProductSiteLaunchDate : 2018-07-12T08:00:01.000Z
StreetDate : 2018-07-12T00:00:01Z
SupplierDeclaredDgHzRegulation : not_applicable
UnitCount : 4
UnspscCode : 42140000

Questions & Answers

Have a question? Ask experts

?
No question found

Ratings & Review

Rating Breakdown (average)

5*
11
4*
3
3*
1
2*
0
1*
0

Read all 15 customer reviews

Five stars all the way.

This works like a charm.

Extremely satisfied with the product.

High quality and great value.

One of the best things IÕve ever bought.

Performs well under regular usage.

IÕm extremely impressed with this item.

Just what I needed and more.

The product is decent but could be improved.

Impressive quality and durability.

Absolutely fantastic product!

Exactly what I was looking for.

Best in its category!

Will definitely recommend to others.

High quality and great value.

Have an opinion on this page? Let's hear it.